Neurosurgical Oncology

Brain Tumor Treatment in Hyderabad

Written by
Published 4 September 2024Updated 26 March 2026

A brain tumor diagnosis demands expert care — from accurate diagnosis and surgical planning to post-operative oncology and rehabilitation. At Yashoda Hospital Malakpet, Dr. Sayuj Krishnan provides comprehensive brain tumor treatment using microsurgery, neuronavigation, awake craniotomy, and multidisciplinary tumor board review to deliver the safest possible outcomes for patients across Hyderabad and Telangana.

If you are specifically looking for awake brain surgery in Hyderabad, this page explains when awake craniotomy is used, how functional mapping improves safety, and when a dedicated awake brain surgery consultation is appropriate.

Why Patients Trust Dr. Sayuj Krishnan

Why Malakpet Patients Trust Our Team

  • • High-powered microsurgery protecting eloquent brain regions
  • • Advanced neuronavigation and neuromonitoring suites in Yashoda Malakpet
  • • Integrated tumour board with oncology, radiology, and pathology support
  • • Dedicated counselling for families throughout diagnosis and recovery

When to See a Neurosurgeon (Red Flag Symptoms)

Early detection of brain tumors significantly improves surgical outcomes. If you or a loved one experiences these warning signs, immediate evaluation is crucial.

Morning Headaches

Severe headaches upon waking, often accompanied by vomiting, which may indicate increased pressure.

New-Onset Seizures

Any first-time seizure in an adult requires an MRI to rule out a tumor or structural lesion.

Focal Deficits

Progressive weakness in one side of the body, difficulty speaking, or sudden vision changes.

Brain Tumor Treatment Options Available in Hyderabad

Treatment for a brain tumor depends on its type, grade, size, and location. Not every brain tumor requires immediate surgery — some are monitored, while others benefit from a combination of approaches. At Yashoda Hospital, we offer the full spectrum of treatment and personalise the plan through our multidisciplinary tumor board.

Microsurgical Excision

The primary treatment for most brain tumors. We use neuronavigation-guided microsurgery to achieve maximal safe resection — removing as much tumor as possible while protecting speech, motor, and cognitive functions.

Suited for: Gliomas, meningiomas, metastatic tumors

Awake Craniotomy

For tumors near speech or motor areas, the patient remains awake during surgery so we can map and protect these functions in real time. This technique allows more aggressive removal with lower neurological risk.

Suited for: Tumors in eloquent cortex, low-grade gliomas

Endoscopic Skull Base Surgery

Minimally invasive transnasal approach for pituitary adenomas and skull base lesions. No external incision — the tumor is accessed through the nose, resulting in faster recovery and shorter hospital stays.

Suited for: Pituitary tumors, craniopharyngiomas, clival lesions

Stereotactic Biopsy

When a tumor is deep-seated or in an area that makes excision risky, a needle biopsy under stereotactic guidance provides a tissue diagnosis to guide chemotherapy and radiation planning.

Suited for: Deep gliomas, lymphomas, diffuse tumors

Radiation Therapy

Post-surgical radiation (fractionated or stereotactic radiosurgery) targets residual tumor cells. We coordinate with radiation oncologists at Yashoda for seamless adjuvant therapy planning.

Suited for: Post-op gliomas, small metastases, residual meningiomas

Chemotherapy & Targeted Therapy

For high-grade gliomas (Grade III–IV), oral temozolomide or newer targeted agents are used alongside surgery and radiation. Our neuro-oncology team manages the full protocol.

Suited for: Glioblastoma, anaplastic astrocytoma, oligodendrogliomas

Treatment decisions are made after tumor board review — a joint discussion by neurosurgeons, neuro-oncologists, radiation oncologists, and neuropathologists. This ensures every patient receives an evidence-based, personalised plan.

How Brain Tumors Are Diagnosed in Hyderabad

Accurate diagnosis is the foundation of effective brain tumor treatment. At Yashoda Hospital, we use a combination of advanced imaging, functional mapping, and laboratory tests to determine the exact type, grade, and location of your tumor — which directly guides the treatment plan.

MRI Brain with Contrast (3 Tesla)

The primary diagnostic tool for brain tumors. A 3T MRI provides high-resolution images that reveal tumor size, exact location, surrounding edema (swelling), and relationship to critical brain structures. Contrast enhancement (gadolinium) helps distinguish tumor tissue from normal brain and identifies areas of active tumor growth. At Yashoda Malakpet, MRI brain with contrast is available 24/7 for emergency cases.

MR Spectroscopy (MRS)

This advanced MRI technique analyses the chemical composition of the tumor. Elevated choline and reduced NAA (N-acetyl aspartate) levels suggest high-grade malignancy. MRS helps differentiate between tumor recurrence and radiation necrosis — a common diagnostic challenge in patients who have already undergone treatment. It also helps distinguish tumors from infections like brain abscesses.

Functional MRI (fMRI) & DTI Tractography

Before operating on tumors near speech, motor, or visual areas, we perform functional MRI to map these critical brain regions. Diffusion Tensor Imaging (DTI) visualises white matter tracts — the "wiring" of the brain — so we can plan a surgical corridor that avoids damaging important connections. This is especially important for tumors in the dominant hemisphere or near the internal capsule.

CT Scan & CT Angiography

CT scans are often the first imaging done in emergency settings — they quickly show hemorrhage, hydrocephalus, or significant mass effect. CT angiography maps the blood vessels around the tumor, which is critical for surgical planning in highly vascular tumors like hemangioblastomas or tumors near major arteries and venous sinuses.

PET-CT Scan

Positron Emission Tomography combined with CT is used to assess tumor metabolism and detect metastatic spread. In brain tumors, FDG-PET or amino acid PET (like FET-PET) helps grade the tumor non-invasively and identify the most metabolically active region for targeted biopsy. PET-CT is especially valuable for evaluating recurrent gliomas and distinguishing treatment-related changes from true progression.

Histopathology & Molecular Profiling

The definitive diagnosis comes from examining tumor tissue under a microscope. Modern neuropathology goes beyond morphology — we test for molecular markers including IDH1/IDH2 mutations, MGMT promoter methylation, 1p/19q co-deletion, ATRX loss, and Ki-67 proliferation index. These markers determine the WHO 2021 tumor grade and directly influence treatment decisions, particularly for gliomas where IDH status determines whether chemotherapy is beneficial.

Important: If you have been diagnosed with a brain tumor elsewhere and are seeking a second opinion, bring your MRI images on CD (not just the report), any biopsy slides, and blood work. Dr. Sayuj personally reviews all imaging before consultation to provide an informed assessment.

Types of Brain Tumors We Treat

We routinely manage tumours ranging from benign meningiomas to high-grade gliomas. Each treatment plan balances maximal safe resection with protection of critical brain structures. Below are the common types we see at our Hyderabad centre.

Gliomas (Grade I–IV)

From slow-growing pilocytic astrocytomas to aggressive glioblastoma multiforme (GBM). Treatment involves maximal safe resection followed by radiation and temozolomide chemotherapy for high-grade tumors. Molecular markers (IDH, MGMT, 1p/19q) guide prognosis and therapy.Read our GBM survival guide →

Meningiomas & Skull Base Tumors

Most meningiomas are benign and curable with complete surgical removal. Skull base meningiomas near the cavernous sinus or posterior fossa require precision microsurgery to preserve cranial nerve function, sometimes relevant for trigeminal neuralgia.Meningioma treatment guide →

Pituitary Adenomas & Sellar Lesions

Endoscopic transnasal surgery is our preferred approach for most pituitary tumors. Hormone-secreting adenomas (prolactinomas, acromegaly) are managed jointly with endocrinology. Non-functioning adenomas compressing the optic chiasm need timely decompression to preserve vision.Pituitary surgery guide →

Acoustic Neuromas (Vestibular Schwannomas)

These benign tumors of the hearing nerve can cause progressive hearing loss, tinnitus, and balance problems. Microsurgical removal with intraoperative facial nerve monitoring aims to preserve facial function and hearing when possible.Acoustic neuroma guide →

Metastatic Brain Tumors

Brain metastases from lung, breast, or other cancers are increasingly common. Treatment depends on the number and size of lesions — single large metastases benefit from surgical removal, while multiple small lesions may be treated with stereotactic radiosurgery. We coordinate closely with medical oncologists.

Pediatric Brain Tumors

Medulloblastomas, ependymomas, and craniopharyngiomas in children require specialised surgical technique and post-operative care. We work with pediatric oncology and rehabilitation teams to ensure age-appropriate treatment and developmental support throughout recovery.

What to Expect at Yashoda Hospital, Malakpet

Your journey begins with a comprehensive review of symptoms, imaging, and medical history. When surgery is advised, Dr. Sayuj details the planned approach—whether a craniotomy, endoscopic skull base procedure, or biopsy—and explains how neuronavigation and neuromonitoring enhance safety.

Your Treatment Pathway

1

Diagnosis & Staging

Advanced MRI (3T), spectroscopy, and functional imaging to map the tumor.

2

Tumor Board Review

Joint review by neurosurgeons, oncologists, and radiologists to plan the best approach.

3

Pre-Surgical Planning

Neuronavigation setup and anaesthesia safety check (PAC) for clearance.

4

The Surgery

Microsurgical or endoscopic removal using intra-operative monitoring for safety.

5

ICU & Recovery

Close monitoring in Neuro-ICU for 24 hours, followed by ward care.

6

Histopathology & Care

Biopsy report discussion and referral for radiation/chemo if required.

Advanced Surgical Techniques

Neuronavigation Microsurgery

Real-time navigation systems ensure maximal safe tumor resection while preserving eloquent brain structures.

Awake Craniotomy & Functional Mapping

Speech and motor mapping techniques protect critical pathways during tumor removal in eloquent cortex.

Multidisciplinary Tumor Board

Collaborative care with neuro-oncology, radiation oncology, and rehabilitation teams for comprehensive plans.

Treatment Outcomes & What to Expect

Outcomes vary significantly by tumor type. Here is a realistic overview based on published medical literature and our clinical experience at Yashoda Hospital.

Benign Tumors (Meningiomas, Schwannomas)

Complete surgical removal is curative in the majority of cases. Recurrence rates after gross total resection are less than 5% at 5 years for WHO Grade I meningiomas. Most patients return to normal daily activities within 4-6 weeks.

Pituitary Adenomas

Endoscopic transnasal surgery achieves biochemical remission in 80-90% of hormone-secreting adenomas. Vision improvement occurs in over 85% of patients with visual field deficits. Hospital stay is typically 2-3 days with most patients resuming work in 2 weeks.

Low-Grade Gliomas (Grade I-II)

Early maximal safe resection followed by monitoring (and adjuvant therapy when indicated) offers median survival exceeding 10-15 years in many cases. IDH-mutant tumors carry a significantly better prognosis. Seizure control improves in over 70% of patients after surgery.

High-Grade Gliomas (Grade III-IV)

Maximal safe resection combined with radiation and temozolomide chemotherapy (the Stupp protocol) is the standard of care. Extent of resection is the strongest modifiable prognostic factor — which is why neuronavigation and awake craniotomy are critical for achieving safe, maximal removal.

Outcomes data based on published peer-reviewed literature. Individual results vary based on tumor characteristics, patient health, and response to treatment. Dr. Sayuj discusses expected outcomes specific to your case during consultation.

Brain Tumor Surgery Recovery Timeline

Understanding the recovery process helps patients and families prepare for the journey ahead. While every patient's recovery is unique — depending on tumor type, size, location, and whether adjuvant therapy is needed — here is a general timeline based on our experience with craniotomy patients at Yashoda Hospital.

Day 0

Surgery Day

Surgery typically lasts 3-6 hours depending on tumor complexity. You are transferred to the Neuro-ICU for close neurological monitoring. The nursing team performs hourly assessments of consciousness, pupil response, limb movement, and speech. Pain management begins immediately — most patients report manageable discomfort with standard analgesics.

Day 1-2

ICU Monitoring & Early Mobilisation

A post-operative CT scan is done within 24 hours to confirm adequate tumor removal and rule out complications like bleeding. If stable, you begin sitting up, taking oral fluids, and the Foley catheter and arterial line are removed. Our physiotherapy team starts gentle bedside exercises. The surgical drain (if placed) is typically removed by Day 2.

Day 3-5

Ward Care & Walking

You move from ICU to a private ward room. Most patients are walking with supervision by Day 3. The surgical wound is inspected daily and skin staples remain in place. Diet progresses to normal. Anti-seizure medication dosing is optimised. The pathology team provides a preliminary histopathology report, which Dr. Sayuj discusses with you and your family.

Week 1-2

Discharge & Home Recovery

Most patients are discharged by Day 5-7. You receive written discharge instructions covering wound care, medications, activity restrictions, and warning signs to watch for. Staple removal happens at the 10-day follow-up visit. Light indoor activities are encouraged. Avoid lifting heavy objects, driving, or strenuous exercise. Fatigue is normal and improves gradually.

Week 3-6

Gradual Return to Normal Life

By 3 weeks, most patients are independent with daily activities. The final histopathology report with molecular markers is usually available by this time, and a tumor board meeting determines whether adjuvant therapy (radiation, chemotherapy) is needed. If yes, referrals to radiation oncology and medical oncology are coordinated. Many patients return to desk work by 4-6 weeks.

Month 3+

Follow-Up MRI & Long-Term Surveillance

The first follow-up MRI with contrast is done at 3 months post-surgery to establish a new baseline. For benign tumors with complete removal, subsequent MRIs are done at 6 months, 1 year, then annually for 5 years. For gliomas, MRI frequency depends on the grade — typically every 3-4 months for the first 2 years. Anti-seizure medications may be tapered if no seizures have occurred. Full neuropsychological recovery continues for up to 6-12 months.

Recovery varies: Patients with smaller, superficial tumors (e.g. convexity meningiomas) recover faster than those with deep-seated or large tumors requiring extended surgery. Patients who need post-operative radiation or chemotherapy may experience additional fatigue. Our team provides a personalised recovery roadmap before discharge.

Comprehensive Patient Support

  • Second-opinion service for complex tumors and recurrent disease
  • Pre-surgical counselling with caregiver briefing and digital resources
  • Post-operative ICU monitored care with daily neurosurgeon rounds
  • Rehabilitation pathways for speech, swallowing, and motor recovery
  • Financial counselling for insurance and corporate approvals

Brain Tumor Case Studies from Hyderabad

Real patient experiences (anonymised for privacy) illustrate the range of brain tumors we treat and the outcomes achieved. Every case is unique, and these examples are shared for educational purposes only.

Benign TumorPatient: 45-year-old woman from Secunderabad

Large Convexity Meningioma with Progressive Weakness

Presentation: Gradual onset of right-sided weakness over 3 months, with increasing difficulty walking and fine motor tasks. MRI revealed a 6 cm parasagittal meningioma compressing the motor cortex with significant surrounding brain edema.

Treatment: Neuronavigation-guided craniotomy with microsurgical excision. Intraoperative motor evoked potential (MEP) monitoring was used throughout to protect the motor pathway. The tumor was completely removed (Simpson Grade I resection) with the dural attachment cauterised.

Outcome: The patient showed immediate improvement in limb strength post-operatively. By 6 weeks, power had returned to near-normal (Grade 4+/5). Histopathology confirmed WHO Grade I meningioma. At 18-month follow-up, MRI shows no recurrence and the patient has returned to all normal activities.

Hospital stay: 6 days. No adjuvant therapy required.

Pituitary TumorPatient: 38-year-old man from Warangal

Non-Functioning Pituitary Macroadenoma with Vision Loss

Presentation: Progressive bilateral peripheral vision loss over 6 months, initially mistaken for an eye problem. Ophthalmology found bitemporal hemianopia (tunnel vision). MRI showed a 3.5 cm pituitary macroadenoma compressing the optic chiasm with suprasellar extension.

Treatment: Endoscopic transnasal transsphenoidal surgery — a minimally invasive approach through the nose with no external incision. The tumor was debulked to decompress the optic chiasm. Lumbar drain was placed for 48 hours as a precaution against CSF leak. Endocrinology evaluation confirmed no hormonal deficiency pre- or post-operatively.

Outcome: Visual field testing at 1 month showed significant improvement — peripheral vision returned to near-normal bilaterally. The patient was discharged on Day 3 with nasal packing removed. At 12-month follow-up, MRI shows a small residual tumor being monitored with serial imaging. No further surgery anticipated.

Hospital stay: 3 days. Vision recovery: significant improvement within 4 weeks.

High-Grade GliomaPatient: 52-year-old man from Hyderabad

Glioblastoma (GBM) — Awake Craniotomy Near Speech Area

Presentation:New-onset seizure followed by word-finding difficulty. MRI showed an enhancing 4 cm mass in the left frontal lobe, adjacent to the Broca's area (speech production centre). Preoperative functional MRI confirmed the tumor was within 1 cm of the speech region.

Treatment: Awake craniotomy with real-time speech mapping. During the awake phase, the patient performed continuous naming and counting tasks while the surgeon used bipolar stimulation to map speech boundaries. This allowed maximum tumor resection while stopping short of the speech cortex. Neuronavigation confirmed greater than 95% volumetric resection on the post-operative MRI.

Outcome: The patient preserved his speech function completely — no post-operative aphasia. Histopathology confirmed IDH-wildtype glioblastoma, MGMT unmethylated. He was started on the Stupp protocol (concurrent radiation + temozolomide) 4 weeks after surgery. At 9-month follow-up, the tumor remains controlled with stable disease on MRI.

Hospital stay: 5 days. Speech preserved. Currently on adjuvant chemotherapy.

These are representative cases shared with patient consent for educational purposes. Names and identifying details have been changed. Individual outcomes vary — please discuss your specific situation with Dr. Sayuj.

Living with a Brain Tumor: Long-Term Care & Quality of Life

A brain tumor diagnosis changes life for patients and families. Whether your tumor was completely removed or you are living with a managed condition, understanding long-term care is essential for maintaining quality of life.

Seizure Management

Many brain tumor patients require anti-epileptic drugs (AEDs) after surgery. The choice of medication depends on tumor type, location, and whether you had seizures before surgery. Common medications include levetiracetam (Levipil/Keppra) and lacosamide. If you have been seizure-free for 1-2 years after surgery and the tumor is completely removed, your neurosurgeon may gradually taper the medication under close monitoring.

Cognitive Rehabilitation

Brain surgery, radiation, and chemotherapy can all affect memory, attention, and processing speed. These effects are often temporary but can persist in some patients. Neuropsychological assessment identifies specific deficits, and cognitive rehabilitation therapy — including memory exercises, attention training, and compensatory strategies — can significantly improve daily function. We refer patients to qualified neuropsychologists in Hyderabad for structured rehabilitation.

Endocrine Follow-Up

Tumors near the pituitary gland or hypothalamus (including pituitary adenomas, craniopharyngiomas, and some gliomas) can disrupt hormone production. Patients may need lifelong hormone replacement — thyroid hormone, cortisol, growth hormone, or sex hormones. Regular endocrinology follow-up with blood tests ensures adequate replacement and catches deficiencies early before they cause symptoms.

Surveillance MRI Schedule

Regular MRI scans are the cornerstone of long-term monitoring. For benign tumors with complete removal, scans are done at 3 months, 6 months, 1 year, then annually for 5 years. For gliomas, scans are more frequent — every 3-4 months initially. Each scan is reviewed by the neurosurgeon and compared with previous images. Any change triggers a tumor board discussion to determine if intervention is needed. Never skip your scheduled MRI — early detection of recurrence improves outcomes.

Returning to Work & Driving

Most patients with benign tumors return to work within 4-8 weeks. Those on adjuvant therapy may need modified schedules during treatment. Driving is generally restricted for at least 3-6 months after brain surgery, especially if you had seizures. Indian law does not have specific brain surgery driving guidelines, but we advise following international standards — seizure-free for at least 6 months before resuming driving. Discuss return-to-work and driving timelines during your follow-up appointments.

Emotional & Family Support

A brain tumor diagnosis affects the entire family. Anxiety about recurrence, changes in personality or mood, and caregiver burnout are common challenges. We encourage patients and families to seek counselling support. Yashoda Hospital has clinical psychologists available for individual and family sessions. Support groups — both in-person and online — connect patients with others who understand the journey. Remember that seeking help is a sign of strength, not weakness.

Why Choose Dr. Sayuj Krishnan for Brain Tumor Surgery

Choosing the right neurosurgeon for brain tumor treatment is one of the most important decisions you will make. Here is what sets our practice apart:

01

Sub-Specialised Neuro-Oncology Training

Dr. Sayuj completed fellowship training in Germany with dedicated exposure to neuro-oncology microsurgery, awake craniotomy, and endoscopic skull base approaches. With over 9 years of neurosurgical experience and brain tumors as a core focus area, he has performed more than 200 brain and spine tumor surgeries at Yashoda Hospital.

02

Full Technology Suite at Yashoda Malakpet

Intraoperative neuronavigation (BrainLab), neurophysiological monitoring (MEP, SSEP, EMG), 3T MRI, high-speed surgical drills, and CUSA (Cavitron Ultrasonic Surgical Aspirator) for gentle tumor removal. The infrastructure matches what you would find at top-tier centres nationally.

03

Multidisciplinary Tumor Board

Every brain tumor case is discussed in a weekly tumor board meeting with radiation oncologists, medical oncologists, neuropathologists, and neuroradiologists. This ensures treatment decisions are evidence-based, unbiased, and tailored to your specific tumor biology — not a one-surgeon opinion.

04

Transparent Communication

Dr. Sayuj personally explains the diagnosis, surgical plan, expected outcomes, and risks in language you understand — in English, Hindi, or Telugu. Families are briefed before and after surgery. You will never feel like a number in a queue. Every question is answered, every concern addressed.

05

Affordable Care with Insurance Support

Brain tumor surgery at Yashoda Hospital Malakpet is significantly more affordable than comparable facilities in metro cities, without any compromise in quality. We support cashless insurance, Aarogyasri, CGHS, ECHS, and corporate health plans. Our TPA desk handles all pre-authorisation paperwork.

06

Continuity of Care

From your first consultation through surgery, post-operative ICU, discharge, adjuvant therapy referral, and years of surveillance MRI follow-up — Dr. Sayuj remains your primary point of contact. There is no handoff to a junior doctor after surgery. This continuity matters when managing a condition that requires long-term monitoring.

Brain Tumor Statistics in India

Understanding the epidemiology of brain tumors helps patients contextualise their diagnosis. India sees a significant burden of central nervous system (CNS) tumors, and Hyderabad is emerging as a major treatment hub for neuro-oncology in South India.

28,000+

New brain tumor cases diagnosed annually in India (ICMR-NCDIR data)

40-60%

Of brain tumors are gliomas (the most common primary brain tumor type)

25-35%

Of brain tumors are meningiomas (most are benign and curable with surgery)

Early diagnosis and access to specialised neurosurgical care significantly improve outcomes across all brain tumor types. If you have been diagnosed with a brain tumor — whether at a local hospital or a major centre — seeking a consultation with a neurosurgeon who specialises in tumor surgery can make a meaningful difference in your treatment plan and long-term prognosis.

Related Conditions

Facial Pain & Skull Base Disorders

Some brain tumors (like acoustic neuromas or meningiomas) can press on cranial nerves, causing facial pain. If you are experiencing severe facial shock-like pain, read our guide on Trigeminal Neuralgia Treatment.

Trusted by Patients Across Telangana & AP

We routinely handle referrals from oncology centres in Secunderabad, Warangal, Nalgonda, Guntur, and Vishakhapatnam. Our coordination team assists with medical visas, accommodation, and digital follow-up, ensuring continuity of care no matter where you live.

Pre-Visit Checklist

  • • Latest MRI brain with contrast and CT angiogram if available
  • • Histopathology reports or biopsy slides for review
  • • Blood investigations and comorbidity records (diabetes, hypertension)
  • • Insurance documentation for cashless admissions

Post-Operative Follow-Up

  • • In-person visits at 1 week, 1 month, and 3 months
  • • Teleconsults for outstation and international patients
  • • Coordination with local oncologists for adjuvant therapy
  • • Rehabilitation and neuropsychology referrals as needed

Estimated Cost of Treatment

Transparent pricing for self-pay patients. Cashless insurance accepted.

ProcedureEstimated Cost Range (INR)Typical RecoveryIncludes
Craniotomy (Tumor Excision)₹2,80,000 - ₹4,50,0005-7 Days (ICU + Ward)
  • Microsurgery
  • Neuronavigation
  • ICU Stay (2-3 days)
Awake Craniotomy₹3,50,000 - ₹5,50,0003-5 Days
  • Functional Mapping
  • Anaesthesia Team
  • Rapid Recovery Protocol
Stereotactic Biopsy₹1,20,000 - ₹1,80,0001-2 Days
  • Needle Biopsy
  • Histopathology
  • Day Care/Short Stay
Endoscopic Skull Base/Pituitary₹3,50,000 - ₹5,50,0003-4 Days
  • Transnasal Approach
  • Endocrinology Review
  • Skull Base Repair

Note: Costs for brain tumor surgery depend heavily on tumor size, ICU duration, and specialized equipment (neuronavigation). The above ranges are indicative. Insurance coverage is available for most procedures.

Insurance & Financial Support

We accept major medical insurance providers for cashless hospitalization at Yashoda Hospitals.

Star HealthHDFC ErgoICICI LombardBajaj AllianzMediAssistVidal HealthFHPLUnited India
EMI options available via Bajaj Finserv & Major Credit Cards.

Clinic Location & Neuro-Oncology Desk

Brain tumor surgeries are performed at Yashoda Hospital, Malakpet, Hyderabad, equipped with hybrid OTs, intraoperative neuromonitoring, and 24/7 critical care. For urgent evaluations, call ahead and our neuro-oncology desk will facilitate immediate imaging review.

Dr. Sayuj Krishnan – Neurosurgeon
Hospital:Room No 317, OPD Block, Yashoda Hospital, Nalgonda X Roads, Malakpet, Hyderabad 500036

Map & Directions

View Location on Map

Click below to load the interactive Google Map for Dr Sayuj Krishnan - Neurosurgeon in Malakpet

Frequently Asked Questions

How quickly can surgery be scheduled after diagnosis?

Urgent cases with progressive neurological deficits are prioritised within 48-72 hours. Elective cases are scheduled after tumour board discussions and pre-anaesthesia evaluation, often within 5-7 working days.

Do you treat patients referred from other hospitals?

Yes. We regularly handle referrals for complex skull base tumours and recurrent gliomas. Bring imaging, histopathology reports, and prior treatment summaries for a complete review.

Is a craniotomy always required for brain tumor treatment?

Not always. Some lesions are best managed with stereotactic biopsy, radiosurgery, or endoscopic skull base approaches. Small, deep-seated tumors may be biopsied and treated with radiation and chemotherapy alone. Surgical planning is individualised based on tumour type, grade, size, and location.

What is awake brain surgery and when is it used?

Awake brain surgery, also called awake craniotomy, is used when a tumor is close to speech, movement, or other eloquent brain areas. During key parts of the operation the patient is awake enough to follow commands, which helps us map and protect important brain functions while removing as much tumor as safely possible.

How long does recovery take after brain tumor surgery?

Most patients spend 1-2 days in the ICU for monitoring and move to the ward for another 3-4 days. You can usually return to light daily activities within 2-3 weeks. Full recovery — including any speech or motor rehabilitation — depends on the specific tumor type, location, and whether adjuvant therapy (radiation/chemotherapy) is needed.

What is the cost of brain tumor surgery in Hyderabad?

Brain tumor surgery costs in Hyderabad vary based on tumor complexity, ICU stay duration, and technology used. Stereotactic biopsies start from approximately ₹1,20,000. Craniotomy with neuronavigation ranges from ₹2,80,000 to ₹4,50,000. Awake craniotomy and complex skull base procedures may range from ₹3,50,000 to ₹5,50,000. We provide transparent estimates after reviewing your MRI, and most procedures are covered under health insurance.

What is the survival rate for brain tumor surgery?

Survival depends heavily on tumor type and grade. Benign tumors like meningiomas and acoustic neuromas have excellent outcomes — most patients are cured with complete surgical removal. For high-grade gliomas (glioblastoma), surgery combined with radiation and chemotherapy significantly improves survival compared to biopsy alone. Molecular markers like IDH mutation and MGMT methylation help predict individual prognosis.

Can brain tumors be treated without surgery?

In some cases, yes. Small, asymptomatic meningiomas may be monitored with serial MRI scans. Certain deep-seated lymphomas respond well to chemotherapy and radiation without surgery. Prolactinomas (a type of pituitary tumor) are often treated with medication alone. However, most symptomatic brain tumors benefit from surgical removal or biopsy to confirm the diagnosis and relieve pressure on the brain.

What is neuronavigation and why is it important?

Neuronavigation is a GPS-like system used during brain surgery. It merges your pre-operative MRI with the surgical field in real time, allowing the surgeon to precisely locate the tumor and avoid critical brain structures. This technology enables smaller incisions, more complete tumor removal, and reduces the risk of neurological complications.

How do I get a second opinion for brain tumor treatment?

You can book a consultation with Dr. Sayuj Krishnan by calling +91-9778280044 or through the online appointment form. Bring your MRI scans (on CD or uploaded to a cloud link), any biopsy reports, and a summary of prior treatments. We offer both in-person and teleconsultation options for patients outside Hyderabad.

Is brain tumor surgery covered by insurance in India?

Yes. Brain tumor surgery is covered under most health insurance policies in India, including cashless treatment at Yashoda Hospital Malakpet. Our financial counselling team assists with pre-authorisation, claim filing, and corporate approvals. Government health schemes like Aarogyasri and CGHS are also accepted.

Explore Brain Tumor Resources

Brain Tumor Resources & Guides

We publish evidence-based articles to help patients and families understand their diagnosis, treatment options, and recovery journey.

Visit Our Neurosurgery Clinics in Hyderabad

Expert neurosurgical care available at multiple convenient locations across Hyderabad.

Clinical References

External links are provided for transparency and do not represent sponsorships. Each source was accessed on 19 Oct 2025.

Medically reviewed by Consultant Neurosurgeon, Yashoda Hospital MalakpetLast reviewed 26 March 2026

This information is for educational purposes only and should not replace professional medical advice. Please consult with Dr. Sayuj for personalized medical guidance.